ARCHIVES

Task Force Recommendations Submitted For Control/Centers New Division

This article is from The Cancer Letter archive.

Vol. 05 No. 31 | August 3, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

NIH Defines Misconduct

December 9, 1994

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

Majority Of U.S. Cancer Patients Receive High-Quality Care, ASCO Study Finds

July 29, 2005